Skip to main content
. 2009 Feb 19;94(4):496–506. doi: 10.3324/haematol.13612

Figure 1.

Figure 1.

Significant differences between lymphocytes of MDS patients and healthy donors. I refers to healthy donor group, II to MDS patient group (A) Differences in percentage naïve CD8+ cells (CD8+/CD45RA+/CD27+). (B) Differences in percentage effector CD8+ cells (CD8+/CD45RA+/CD27). (C) Differences in percentage CD8+ granzyme+ T cells. (D) Differences in MFI FOXP3 in regulatory T cells (CD4+/CD25high).